Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Healthcare

Former Dental Giant’s Legal Saga Continues as Claim Deadline Approaches

Andreas Sommer by Andreas Sommer
October 5, 2025
in Healthcare, Mergers & Acquisitions, Nasdaq, Penny Stocks
0
SmileDirectClub Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

The dramatic corporate collapse of SmileDirectClub continues to generate legal activity long after the company’s operational demise. Once a pioneering force in teledentistry, the now-bankrupt enterprise maintains courtroom relevance through multiple ongoing legal proceedings. While the company’s shares were removed from the Nasdaq exchange and now trade as penny stocks over-the-counter under the ticker SDCCQ, former customers face a critical deadline.

Crucial Compensation Window Closing Soon

A significant antitrust settlement presents a final opportunity for reimbursement to eligible customers. Those who purchased aligners from SmileDirectClub between October 2017 and August 2022 may claim compensation ranging from $40 to $60. The absolute deadline to file these claims falls on October 27, 2025, after which no further applications will be accepted.

This $31.75 million settlement with Align Technology, manufacturer of Invisalign, addresses allegations that anticompetitive arrangements artificially inflated prices for dental aligners. Although SmileDirectClub no longer operates, the legal consequences of its business practices continue to unfold.

Additional Refund Programs Active

Simultaneously, a separate restitution program is underway following action by New York’s Attorney General, who secured $4.8 million in refunds for customers who experienced continued billing after the company’s bankruptcy declaration. This additional avenue for reimbursement highlights the complex aftermath facing former clients.

Should investors sell immediately? Or is it worth buying SmileDirectClub?

From Market Leader to Complete Liquidation

The company’s downfall represents a stunning reversal of fortune for an enterprise once valued at $8.9 billion. After filing for Chapter 11 bankruptcy protection in September 2023, SmileDirectClub underwent complete liquidation. Its technology assets were acquired by SmileSet, while its core business operations ceased entirely.

The shares, now virtually worthless, serve as a stark reminder of the company’s precipitous decline from industry disruptor to defunct entity.

Ongoing Legal Challenges

Beyond customer compensation claims, additional legal proceedings continue to work through the court system. Former partners and additional claimants are pursuing various actions, including litigation alleging violations of the WARN Act regarding employee termination procedures during the company’s final days.

The question of who might ultimately benefit from the remnants of this former market leader remains with the courts—and with investors and customers who file their claims before approaching deadlines.

Ad

SmileDirectClub Stock: Buy or Sell?! New SmileDirectClub Analysis from January 11 delivers the answer:

The latest SmileDirectClub figures speak for themselves: Urgent action needed for SmileDirectClub investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 11.

SmileDirectClub: Buy or sell? Read more here...

Tags: SmileDirectClub
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Palantir Stock
AI & Quantum Computing

Palantir Shares: A Wall Street Divide and a Bold New Price Target

January 11, 2026
Netflix Stock
Analysis

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

January 11, 2026
Freshworks Stock
Analysis

Freshworks Shares Gain on Strategic Pricing and Acquisition Moves

January 10, 2026
Next Post
Realty Income Stock

Institutional Investors Flock to Realty Income as Insiders Reduce Stakes

Pinterest Stock

A Tale of Two Strategies: Pinterest's Bullish Institutions Versus Bearish Insiders

Madrigal Stock

Madrigal Stock: A Biotech Powerhouse's Meteoric Rise

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com